World

Shares of Australian biotech major CSL plunge 17% after CEO departure, weak earnings

TORRETORRE
Feb 11, 2026 - 02:00
 0
Shares of Australian biotech major CSL plunge 17% after CEO departure, weak earnings
Shares of biotech company CSL plunged after the company announced that Chief Executive Officer Paul McKenzie will step down.
Read More
TORRE
TORRE

Related Posts

CNBC Daily Open: AI might come for financial firms next — and a weak U.S. retail report weighs on stocks

CNBC Daily Open: AI might come for financial firms next...

TORRE Feb 11, 2026  0

Russia Further Restricts Telegram, Escalating Internet Clampdown

Russia Further Restricts Telegram, Escalating Internet ...

TORRE Feb 11, 2026  0

Chappell Roan Leaves Casey Wasserman Agency Over Epstein Files

Chappell Roan Leaves Casey Wasserman Agency Over Epstei...

TORRE Feb 11, 2026  0

Tehran prepared for both diplomacy and war – Iranian FM

Tehran prepared for both diplomacy and war – Iranian FM

TORRE Feb 11, 2026  0

Asia markets mostly rise as investors shrug off weak U.S. retail sales, assess China inflation

Asia markets mostly rise as investors shrug off weak U....

TORRE Feb 11, 2026  0

The AI threat wrecked software stocks. Now financial stocks look next with LPL closing 8% lower

The AI threat wrecked software stocks. Now financial st...

TORRE Feb 11, 2026  0